Myomo Inc. (MYO)

Price$1.28

Value ScoreB

Growth ScoreC

Momentum ScoreB

Favorite Metrics

Price vs S&P 500 (26W)35.90%

Price vs S&P 500 (4W)54.60%

VGM Score63.19

Market Capitalization$49.46M

All Metrics

Book Value / Share (Quarterly)$0.23

P/TBV (Annual)3.56x

Revenue Growth (3Y)38.05%

Cash Flow / Share (Quarterly)$-0.45

Price vs S&P 500 (YTD)32.50%

Gross Margin (TTM)65.96%

Net Profit Margin (TTM)-36.69%

EPS (TTM)$-0.36

10-Day Avg Trading Volume1.10M

EPS Excl Extra (TTM)$-0.36

Revenue Growth (5Y)40.10%

EPS (Annual)$-0.37

ROI (Annual)-68.83%

Gross Margin (Annual)65.70%

Net Profit Margin (5Y Avg)-48.63%

Cash / Share (Quarterly)$0.41

Revenue Growth QoQ (YoY)2.86%

ROA (Last FY)-40.31%

Revenue Growth TTM (YoY)6.68%

EBITD / Share (TTM)$-0.31

ROE (5Y Avg)-97.63%

Operating Margin (TTM)-34.07%

Cash Flow / Share (Annual)$-0.46

P/B Ratio5.49x

P/B Ratio (Quarterly)2.89x

Net Income / Employee (Annual)$-80,300

EV / Revenue (TTM)1.19x

Net Interest Coverage (TTM)-21.58x

ROA (TTM)-40.82%

EPS Incl Extra (Annual)$-0.37

Current Ratio (Annual)3.30x

Quick Ratio (Quarterly)2.19x

3-Month Avg Trading Volume0.47M

52-Week Price Return-57.19%

Revenue / Employee (TTM)$212,400

Tangible BV / Share (Quarterly)$0.19

P/S Ratio (Annual)1.21x

Asset Turnover (Annual)1.06x

52-Week High$3.08

Operating Margin (5Y Avg)-47.95%

EPS Excl Extra (Annual)$-0.37

CapEx CAGR (5Y)135.77%

Tangible BV CAGR (5Y)-12.57%

26-Week Price Return43.82%

Quick Ratio (Annual)2.69x

13-Week Price Return52.38%

Total Debt / Equity (Annual)0.98x

Current Ratio (Quarterly)2.73x

Enterprise Value$48.99M

Revenue / Share Growth (5Y)-15.56%

Asset Turnover (TTM)1.11x

Book Value / Share Growth (5Y)-34.81%

Revenue / Employee (Annual)$211,000

Inventory Turnover (Annual)4.46x

Pretax Margin (Annual)-36.82%

Cash / Share (Annual)$0.48

3-Month Return Std Dev88.17%

Gross Margin (5Y Avg)69.15%

Net Income / Employee (TTM)$-77,900

ROE (Last FY)-136.57%

Net Interest Coverage (Annual)-6.51x

EPS Basic Excl Extra (Annual)$-0.37

Receivables Turnover (TTM)8.69x

Total Debt / Equity (Quarterly)1.21x

EPS Incl Extra (TTM)$-0.36

Receivables Turnover (Annual)10.33x

ROI (TTM)-73.04%

P/S Ratio (TTM)1.20x

Pretax Margin (5Y Avg)-47.78%

Revenue / Share (Annual)$0.98

Tangible BV / Share (Annual)$0.26

Price vs S&P 500 (52W)-81.56%

Year-to-Date Return40.66%

5-Day Price Return10.34%

EPS Normalized (Annual)$-0.37

ROA (5Y Avg)-53.59%

Net Profit Margin (Annual)-38.05%

Month-to-Date Return17.43%

Cash Flow / Share (TTM)$-0.32

EBITD / Share (Annual)$-0.32

Operating Margin (Annual)-35.19%

LT Debt / Equity (Annual)0.98x

ROI (5Y Avg)-84.08%

LT Debt / Equity (Quarterly)1.21x

EPS Basic Excl Extra (TTM)$-0.36

P/TBV (Quarterly)3.59x

P/B Ratio (Annual)3.07x

Inventory Turnover (TTM)4.06x

Pretax Margin (TTM)-35.34%

Book Value / Share (Annual)$0.30

Price vs S&P 500 (13W)44.13%

Beta1.46x

Revenue / Share (TTM)$0.97

ROE (TTM)-114.87%

52-Week Low$0.60

vGradeB

gGradeC

mGradeB

vgmGradeB

Show chart for

Earnings Surprise History

Q1 26-0.05est. -0.12

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.00

Industry Peers — Orthopedic & Prosthetic Devices(33)

Symbol	Value Score	Growth Score	Momentum Score	Price
MYOMyomo Inc.	B	C	B	$1.28
ISRGIntuitive Surgical Inc.	F	B	C	$422.06
EWEdwards Lifesciences Corp	D	C	C	$85.96
STESTERIS plc	C	B	C	$212.35
ZBHZimmer Biomet Holdings, Inc.	B	C	C	$87.33
ALGNAlign Technology Inc	B	C	C	$167.74
SNNSmith & Nephew plc	B	C	C	$30.61
MSAMine Safety Incorporated	B	C	C	$161.30
ESTAEstablishment Labs Holdings Inc.	F	A	B	$74.31
ENOVEnovis Corporation	B	D	C	$23.78
CDRECadre Holdings, Inc.	C	C	D	$30.01

About

Myomo Inc manufactures MyoPro, an FDA-cleared Class II myoelectric orthosis designed to restore upper limb function in patients with neuromuscular disorders. The company distributes through orthotics and prosthetics providers worldwide and the Veterans Health Administration, while generating revenue through direct insurance billing for patient usage.